Metabolic effects of carvedilol in hypertensive patients

European Journal of Clinical Pharmacology

Volumn 52, Issue 1, 1997, Pages 13-17

  Lithell, Hans ^a   Andersson, Per Erik ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

carvedilol; glucose tolerance; hypertension; insulin sensitivity; lipids

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE TOLERANCE; HUMAN; INSULIN SENSITIVITY; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARBAZOLES; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROPANOLAMINES; SINGLE-BLIND METHOD;

EID: 0030970174     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050242     Document Type: Article

References (15)

1. Abshagen U (1987) A new molecule with vasodilating and β-adrenoceptor blocking properties. J Cardiovasc Pharmacol 10 [Suppl 11]: S23-S32
2. Rittinghausen R (1988) Response rate with respect to the blood pressure lowering effect of the vasodilating and β-blocking agent carvedilol. Drugs 36 [Suppl 6]: 92-101
3. Ruffolo Jr RR, Boyle DA, Brooks DP, Feuerstein GZ, Venuti RP, Lukas MA, Poste G (1992) Carvedilol: a novel cardiovascular drug with multiple actions. Cardiovasc Drug Rev 10: 127-157
4. Ames RP (1986) The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs. Drugs 32: 335-357
5. Pollare T, Lithell H, Mörlin C, Präntare H, Hvarfner A, Ljunghall S (1989) Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups. J Hypertens 7: 551-559
6. Pollare T, Lithell H, Selinus I, Berne C (1989) Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. Br Med J 298: 1152-1157
7. Lithell H, Pollare T, Vessby B (1992) Metabolic effects of pindolol and propranolol in a double-blind cross-over study in hypertensive patients. Blood Pressure 1: 92-101
8. Pollare T, Lithell H, Selinus I, Berne C (1988) Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension. Diabetologia 31: 415-420
9. Ikkos D, Luft R (1957) On the intravenous glucose tolerance test. Acta Endocrinol (Kbh.) 25: 312-334
10. DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 237: E214-E223
11. Siegler L, Wu TW (1981) Separation of serum high-density lipoprotein for cholesterol determination: ultracentrifugation vs precipitation with sodium phosphotungstate and magnesium chloride. Clin Chem 27: 838-841
12. Lithell H, Weiner L, Vessby B, Nordström ML (1993) Effects of small doses of bisoprolol on blood pressure and lipoprotein concentrations in hypertensive patients. Eur J Clin Pharmacol 44: 19-22
13. Langdon CG, Baxter GA, Young PH (1991) A multicenter comparison of carvedilol with hydrochlorothiazide in the treatment of mild to moderate essential hypertension. J Cardiovasc Pharmacol 18 [Suppl 4]: S51-S56
14. Schnurr E, Widmann L, Glocke M (1987) Efficacy and safety of carvedilol in the treatment of hypertension. J Cardiovasc Pharmacol 10 [Suppl 11]: S101-S107
15. Seguchi H, Nakamura H, Jaosaki N, Homma Y, Mikami Y, Takahashi S (1990) Effects of carvedilol on serum lipids in hypertensive and normotensive subjects. Eur J Clin Pharmacol 38 [Suppl 2]: S139-S142